| 000 | 01731 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516034216.0 | ||
| 264 | 0 | _c20110906 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1522-1547 | ||
| 024 | 7 |
_a10.1152/ajpgi.00039.2011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRowland, Katherine J | |
| 245 | 0 | 0 |
_aThe "cryptic" mechanism of action of glucagon-like peptide-2. _h[electronic resource] |
| 260 |
_bAmerican journal of physiology. Gastrointestinal and liver physiology _cJul 2011 |
||
| 300 |
_aG1-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Transformation, Neoplastic _xchemically induced |
| 650 | 0 | 4 |
_aColonic Neoplasms _xchemically induced |
| 650 | 0 | 4 |
_aFibroblast Growth Factor 7 _xmetabolism |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide 2 _xadverse effects |
| 650 | 0 | 4 | _aGlucagon-Like Peptide-2 Receptor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xmetabolism |
| 650 | 0 | 4 |
_aIntestines _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Glucagon _xagonists |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSomatomedins _xmetabolism |
| 650 | 0 | 4 |
_aStem Cells _xdrug effects |
| 650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xpharmacology |
| 700 | 1 | _aBrubaker, Patricia L | |
| 773 | 0 |
_tAmerican journal of physiology. Gastrointestinal and liver physiology _gvol. 301 _gno. 1 _gp. G1-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpgi.00039.2011 _zAvailable from publisher's website |
| 999 |
_c20792317 _d20792317 |
||